A Computational Analysis of the Synergistic Effect of Coagulation Inhibitors on the Generation of Thrombin
暂无分享,去创建一个
Kevin Ward | Lemont B. Kier | Umesh R. Desai | Nathan B. Menke | Chao-Kun Cheng | L. Kier | K. Ward | Chao-Kun Cheng | N. Menke | U. Desai
[1] Donghui Zhu,et al. Mathematical modeling of blood coagulation cascade: kinetics of intrinsic and extrinsic pathways in normal and deficient conditions , 2007, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.
[2] G. Broze,et al. Regulation of Extrinsic Pathway Factor Xa Formation by Tissue Factor Pathway Inhibitor* , 1998, The Journal of Biological Chemistry.
[3] R. Kaufman,et al. Model for the Factor VIIIa-dependent Decay of the Intrinsic Factor Xase , 1996, The Journal of Biological Chemistry.
[4] H C Hemker,et al. The role of phospholipids and factor Va in the prothrombinase complex. , 1980, The Journal of biological chemistry.
[5] Gary An,et al. Mathematical modeling in medicine: a means, not an end. , 2005, Critical care medicine.
[6] K. Mann,et al. Kinetics of human factor VII activation. , 1996, Biochemistry.
[7] P. Mannucci,et al. Screening Tests for Thrombophilic Patients: Which Tests, for Which Patient, by Whom, When, and Why? , 1998, Seminars in thrombosis and hemostasis.
[8] K. Mann,et al. A model for the tissue factor pathway to thrombin. II. A mathematical simulation. , 1994, Journal of Biological Chemistry.
[9] J Jesty,et al. Kinetics of the inhibition of factor Xa and the tissue factor-factor VIIa complex by the tissue factor pathway inhibitor in the presence and absence of heparin. , 1994, Biochemistry.
[10] Kenneth G. Mann,et al. Regulation of Tissue Factor Initiated Thrombin Generation by the Stoichiometric Inhibitors Tissue Factor Pathway Inhibitor, Antithrombin-III, and Heparin Cofactor-II* , 1997, The Journal of Biological Chemistry.
[11] W. Ruf,et al. Role of Zymogen and Activated Factor X as Scaffolds for the Inhibition of the Blood Coagulation Factor VIIa-Tissue Factor Complex by Recombinant Nematode Anticoagulant Protein c2* , 2001, The Journal of Biological Chemistry.
[12] J. McVey,et al. Surface plasmon resonance studies of the interaction between factor VII and tissue factor. Demonstration of defective tissue factor binding in a variant FVII molecule (FVII-R79Q). , 1994, Biochemistry.
[13] G M Oosta,et al. The kinetics of hemostatic enzyme-antithrombin interactions in the presence of low molecular weight heparin. , 1980, The Journal of biological chemistry.
[14] Steven C Bankes,et al. Agent-based modeling: A revolution? , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[15] B. Furie,et al. Mechanisms of thrombus formation. , 2008, The New England journal of medicine.
[16] Timothy G Buchman,et al. Nonlinear dynamics, complex systems, and the pathobiology of critical illness , 2004, Current opinion in critical care.
[17] P. Fay,et al. Characterization of the interaction between the A2 subunit and A1/A3-C1-C2 dimer in human factor VIIIa. , 1992, The Journal of biological chemistry.
[18] P. Lollar,et al. von Willebrand factor is a cofactor for thrombin-catalyzed cleavage of the factor VIII light chain. , 1990, The Journal of biological chemistry.
[19] H. Messmore,et al. Hemostasis and Thrombosis: Basic Principles and Clinical Practice , 2001 .
[20] D D Monkovic,et al. Activation of human factor V by factor Xa and thrombin. , 1990, Biochemistry.
[21] V. V. van Hinsbergh,et al. Extrinsic activation of human coagulation factors IX and X on the endothelial surface. , 1991, Thrombosis and haemostasis.
[22] W Ruf,et al. Exosite Interactions Determine the Affinity of Factor X for the Extrinsic Xase Complex* , 2000, The Journal of Biological Chemistry.
[23] K. C. Jones,et al. A Model for the Stoichiometric Regulation of Blood Coagulation* , 2002, The Journal of Biological Chemistry.
[24] M. Panteleev,et al. Mathematical models of blood coagulation and platelet adhesion: clinical applications. , 2007, Current pharmaceutical design.
[25] P. Schoen,et al. The in situ inhibition of prothrombinase-formed human alpha-thrombin and meizothrombin(des F1) by antithrombin III and heparin. , 1987, The Journal of biological chemistry.
[26] R J Baugh,et al. Role of the Activation Peptide Domain in Human Factor X Activation by the Extrinsic Xase Complex* , 1996, The Journal of Biological Chemistry.
[27] P. Walsh,et al. Kinetics of coagulation factor X activation by platelet-bound factor IXa. , 1990, Biochemistry.
[28] K. Mann,et al. Complex-dependent inhibition of factor VIIa by antithrombin III and heparin. , 1993, The Journal of biological chemistry.
[29] D. Wagner,et al. The vessel wall and its interactions. , 2008, Blood.
[30] S Krishnaswamy,et al. The interaction of human factor VIIa with tissue factor. , 1992, The Journal of biological chemistry.
[31] R E Rider. Aspects of ulam: from cardinals to chaos. , 1989, Science.
[32] S. Olson,et al. Heparin Enhances the Specificity of Antithrombin for Thrombin and Factor Xa Independent of the Reactive Center Loop Sequence , 2001, The Journal of Biological Chemistry.
[33] G An,et al. Agent-based computer simulation and sirs: building a bridge between basic science and clinical trials. , 2001, Shock.
[34] Kenneth G. Mann,et al. Inhibitory Mechanism of the Protein C Pathway on Tissue Factor-induced Thrombin Generation , 1997, The Journal of Biological Chemistry.
[35] Eric Bonabeau,et al. Agent-based modeling: Methods and techniques for simulating human systems , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[36] T S Edgington,et al. Macromolecular Substrate Affinity for the Tissue Factor-Factor VIIa Complex Is Independent of Scissile Bond Docking* , 1999, The Journal of Biological Chemistry.
[37] P. Lollar,et al. Coagulant properties of hybrid human/porcine factor VIII molecules. , 1992, The Journal of biological chemistry.
[38] Dougald M Monroe,et al. What does it take to make the perfect clot? , 2006, Arteriosclerosis, thrombosis, and vascular biology.